<DOC>
	<DOCNO>NCT00973908</DOCNO>
	<brief_summary>The investigator aim investigate whether routine use probiotic formulation VSL # 3 co-prescribed antibiotic reduces incidence Antibiotic associate diarrhoea Clostridium Difficile associate diarrhoea .</brief_summary>
	<brief_title>Probiotics Prevention Antibiotics Associated Diarrhoea Clostridium Difficile Associated Diarrhoea</brief_title>
	<detailed_description>The investigator aim find whether VSL # 3 prevent Antibiotic associate diarrhoea Clostridium Difficile associate diarrhoea VSL # 3 give course systemic antibiotic . Patients randomize 1:1 proportion receive either one sachet VSL # 3 similar look placebo twice day . This give length antibiotic course another week thereafter . Follow-up last 28 day last antibiotic dose . Patient restart antibiotic follow-up restarted trial medication 28 day follow-up recommence . This trial 2 co-primary outcome measure .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Adults age 18 old Hospital inpatient On systemic antibiotic infection Antibiotics start within last 48 hour Diarrhoea screen Unable take enteral med Patients intensive care unit Severe Immunosuppression ( neutropenia , AIDS , congenital immunoparesis , chemotherapy ) Risk endocarditis ( Artificial heart valve , history rheumatic heart disease infective endocarditis ) Regular consumption probiotic 1 week prior admission Acute severe pancreatitis Persistent vomiting ( two day )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Clostridium difficile associate diarrhoea</keyword>
	<keyword>antibiotic associate diarrhoea</keyword>
</DOC>